Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The "Life Science Software Global Market Opportunities And Strategies 2034" has been added to ResearchAndMarkets.com's offering.
Life Science Software Global Market Opportunities and Strategies To 2034 provides vital insights for strategists, marketers, and senior management to evaluate the global life science software market as it emerges from the COVID-19 shutdown. The comprehensive report covers 15 geographies, offering a truly global perspective on the market's recovery and growth.
The life science software market report provides an in-depth analysis, evaluating its growth trajectory across various regions during the historic period (2019-2024) and forecast period (2024-2029 and 2029-2034). The market achieved a significant valuation of nearly $18.08 billion in 2024, experiencing a compound annual growth rate (CAGR) of 12.72% since 2019. Projections indicate the market is expected to surge to $30.85 billion by 2029, progressing further to reach $52.14 billion by 2034, supported by a CAGR of 11.06% from 2029. This growth is primarily fueled by a rising demand for personalized medicine, expansion of clinical trials, outsourcing, and increasing R&D spending.
Challenges in the historic period included complex regulatory compliance and privacy concerns. However, future prospects indicate robust growth driven by the expanding pharmaceutical sector, the prevalence of chronic diseases, demand for real-world evidence, and cloud adoption in medtech. Potential growth hurdles encompass cost pressures in drug discovery, high implementation expenses, and economic trade factors.
Segmenting the market by type, deployment, application, and end-user unveils the descriptive segment as the largest, generating $8.79 billion in 2024, with the prescriptive segment being the fastest-growing at a 15.2% CAGR. On the deployment front, the hosted market reigns supreme with 63% market share in 2024, anticipated to grow at a 13.65% CAGR until 2029. Within applications, R&D leads with a 38.96% share, and expected fastest growth at a 13.17% CAGR, while the biopharmaceutical industry dominates the end-user segment with a 42.83% market share and projected 13.72% CAGR growth through 2029.
Regionally, North America leads, capturing 37.71% of the market in 2024, followed by Asia Pacific and Western Europe. The Asia Pacific and Eastern Europe are set for rapid growth, exhibiting CAGRs of 14.41% and 13.81%, respectively. Asia Pacific's burgeoning market underscores the potential for industry players to expand their footprints.
The market features a fragmented landscape, with key players like Veeva Systems Inc. leading at a 5.32% market share, followed by IQVIA Holdings Inc., Microsoft (Life Sciences), and Oracle Corp. Significant opportunities reside in the descriptive, hosted, R&D, and biopharmaceutical segments, poised to capture billions in additional revenue, particularly within the USA.
Strategically, companies are advised to innovate with AI-driven solutions, enhance data integration, and drive digital transformation through strategic partnerships. Emphasizing next-generation products such as AI-powered pathology solutions, generative AI, and cloud-based tools are paramount. Expansion into emerging markets, effective digital campaigns, and value-based pricing strategies further support growth and market penetration.
Growth strategies include fostering partnerships, enhancing operational capabilities, and focusing on user-centric, data-driven innovations. This targeted approach aims to leverage current trends and capitalize on burgeoning market opportunities, ensuring sustained market leadership amidst competitive pressures.
Chapter Highlights
- Introduction and Market Characteristics - Covers segmentations by type, deployment, application, and end user.
- Key Trends - Discusses major global market trends and potential future developments.
- Growth Analysis and Strategic Framework - Examines PESTEL factors, industry growth rates, historical and forecast market values.
- Global Market Size and Growth - Details historic and forecast market values and growth factors.
- Regional and Country Analysis - Provides market values, growth, and market share comparisons by region and country.
- Market Segmentation - Analyzes market segments by type, application, and industry.
- Regional Market Size and Growth - Compares countries' market values and growth in different regions.
- Competitive Landscape - Outlines the competitive environment and company profiles of leading players.
- Other Major and Innovative Companies - Profiles other significant and innovative competitors.
- Competitive Benchmarking - Compares key financials of market players.
- Competitive Dashboard - Provides a snapshot of the competitive landscape.
- Key Mergers and Acquisitions - Offers insights into recent mergers and acquisitions impacting the market.
- Recent Developments - Highlights notable recent market changes.
- Market Opportunities and Strategies - Recommends strategic growth opportunities across segments and regions.
- Conclusions and Recommendations - Provides actionable insights for leveraging market opportunities.
Markets Covered:
- By Type: Predictive, Descriptive, Prescriptive
- By Deployment: On-Premises, Hosted
- By Application: Marketing, Compliance, R&D, Pharmacovigilance, SCM
- By End User: Healthcare Institutes, Biopharmaceutical Industry, Medical Devices Industry, Medical Research Centers
Companies Featured
- Veeva Systems Inc.
- IQVIA Holdings, Inc.
- Microsoft (Life Sciences)
- Oracle Corp.
- Dassault Systemes SE (Medidata Solution Inc.)
- SAP SE
- UnitedHealth Group Incorporated (Optum Inc.)
- Thermo Fisher Scientific Inc.
- PerkinElmer
- Certara
- IBM
- Fujitsu Ltd
- DXC Technology Co
- Fred IT Group
- 4D Medical
- Bioclinica (Now part of Clario)
- Agaram Technologies
- Freyr Solutions
- Anaut Inc.
- Olympus Corporation
- YiduCloud (Yidu Tech)
- LinkDoc Technology
- iHridAI
- InMed AI
- Deep Bio
- Clarivate
- IDBS
- Aureus Sciences
- Instem
- Sophia Genetics
- Yumasoft
- BioSolveIT
- SAP SE
- Biocodex
- Salesforce Health Cloud
- Semaphore
- Biocodexand Arlenda
- Novel Software Systems
- Intelliseq
- Veeva Systems
- Medidata Solutions (a Dassault Systemes company)
- ArisGlobal
- Certara
- Schrodinger
- Benchling
- Instem
- Trinity Life Sciences
- Indica Labs
- Valsoft Corporation
- Siemens
- Axtria Inc.
- Nicoya Lifesciences
- BenchSci
- Cyclica
- Zymewire
- Dassault Systemes
- PBR Life Sciences
- HealthQ Technologies
For more information about this report visit https://www.researchandmarkets.com/r/urfr59
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
